Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells.
PARP inhibitors have been developed as anti-cancer agents based on synthetic lethality in homologous recombination deficient cancer cells. However, resistance to PARP inhibitors such as olaparib remains a problem in clinical use, and the mechanisms of resistance are not fully understood. To investig...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Acceso en liña: | https://doi.org/10.1371/journal.pone.0302130 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|